BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17565640)

  • 21. Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model.
    Fujita K; Nozaki Y; Yoneda M; Wada K; Takahashi H; Kirikoshi H; Inamori M; Saito S; Iwasaki T; Terauchi Y; Maeyama S; Nakajima A
    Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S18-24. PubMed ID: 18986378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.
    Yang L; Chan CC; Kwon OS; Liu S; McGhee J; Stimpson SA; Chen LZ; Harrington WW; Symonds WT; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G902-11. PubMed ID: 16798724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats.
    Murayama H; Ikemoto M; Nagata A
    J Gastroenterol Hepatol; 2009 Feb; 24(2):270-7. PubMed ID: 18823438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
    Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Jin H; Sakaida I; Tsuchiya M; Okita K
    Life Sci; 2005 Apr; 76(24):2805-16. PubMed ID: 15808881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis.
    Samuhasaneeto S; Thong-Ngam D; Kulaputana O; Patumraj S; Klaikeaw N
    J Med Assoc Thai; 2007 Apr; 90(4):788-97. PubMed ID: 17487136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.
    Namisaki T; Kaji K; Shimozato N; Kaya D; Ozutsumi T; Tsuji Y; Fujinaga Y; Kitagawa K; Furukawa M; Sato S; Sawada Y; Nishimura N; Takaya H; Okura Y; Seki K; Kawaratani H; Moriya K; Noguchi R; Asada K; Akahane T; Mitoro A; Yoshiji H
    Indian J Gastroenterol; 2022 Apr; 41(2):169-180. PubMed ID: 35279807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
    Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis.
    Aghazadeh S; Amini R; Yazdanparast R; Ghaffari SH
    Exp Toxicol Pathol; 2011 Sep; 63(6):569-74. PubMed ID: 20471811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis.
    Nabeshima Y; Tazuma S; Kanno K; Hyogo H; Iwai M; Horiuchi M; Chayama K
    Biochem Biophys Res Commun; 2006 Aug; 346(3):658-64. PubMed ID: 16774739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats.
    Canguven O; Lagoda G; Sezen SF; Burnett AL
    J Urol; 2009 Jun; 181(6):2816-22. PubMed ID: 19375729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early detection of steatohepatitis in fatty rat liver by using MR elastography.
    Salameh N; Larrat B; Abarca-Quinones J; Pallu S; Dorvillius M; Leclercq I; Fink M; Sinkus R; Van Beers BE
    Radiology; 2009 Oct; 253(1):90-7. PubMed ID: 19587308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal.
    Lukivskaya O; Patsenker E; Lis R; Buko VU
    Eur J Clin Invest; 2008 May; 38(5):317-25. PubMed ID: 18380797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
    Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
    Kamada Y; Matsumoto H; Tamura S; Fukushima J; Kiso S; Fukui K; Igura T; Maeda N; Kihara S; Funahashi T; Matsuzawa Y; Shimomura I; Hayashi N
    J Hepatol; 2007 Oct; 47(4):556-64. PubMed ID: 17459514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of Ob-Rb and its relationship with the overexpression of TGF-beta1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis.
    CayĆ³n A; Crespo J; Mayorga M; Guerra A; Pons-Romero F
    Liver Int; 2006 Nov; 26(9):1065-71. PubMed ID: 17032406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
    Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC
    Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
    Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
    Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Simvastatin inhibits activation of hepatic stellate cells and promotes activation of adenosine monophosphate-activated protein kinase].
    Cao W; Yan L; Wang W; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):304-9. PubMed ID: 22964154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.